Congratulations to Thomas Williams
May 2025
2025 Winthrop P. Rockefeller Cancer Institute Research Retreat.
Thomas Williams has been awarded the Outstanding Graduate Student Poster Award.
Retreat
May 2025
Winthrop P. Rockefeller Cancer Institute Retreat
Developing The Next Generation of Cancer Therapies for Arkansas
- “Enhancement of DNA Repair in T Cells to Improve Immunotherapy Outcomes Against Solid Tumors”, Jessica Kelliher, PhD.
- “ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response”, Jacob Edmondson
- “Investigating Proteomic and Environmental Determinants of CAR T Cell Cytotoxicity”, Katherine Cruse
- “Defining the role for PCK2 in T-cell metabolic plasticity in the solid tumor microenvironment”, Thomas Williams
UAMS Student Research Day
April 2025
“Comprehensive analysis of proteome turnover dynamics during T-cell exhaustion”, Sydnye Shuttleworth
“Defining the role for PCK2 in T-cell metabolic plasticity in the solid tumor microenvironment”, Thomas Williams
Team Science Award
April 2025
Winthrop P. Rockefeller Cancer Institute 2025 Team Science Award
Exploiting PCK2 to enhance T Cell effector function in solid tumors
Katie Cruse Joins the Koss Lab
January 2025
Katie is enrolled UAMS in the GPIBS PhD program and will study the environmental impacts on T cell function and immunotherapy response.
Thomas Williams Joins the Koss Lab
January 2025
Thomas is enrolled UAMS in the GPIBS PhD program and will study the role of PCK2 in T cell function during infiltration of solid tumors.
Jessica Receives ACS Fellowship
January 2025
Congratulations to Dr. Jessica Kelliher on receiving a highly competitive fellowship award from the American Cancer Society (ACS). Dr. Kelliher will use the $217,500, three-year award for a research project aimed at exploiting DNA repair in cell therapy for solid tumors.
SITC 2024
November 2024
39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024) Houston, TX
- “ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response”, Jacob Edmondson
- “Defining the role of PCK2 in T-cell metabolic plasticity in the solid tumor microenvironment”, Katie Wallis
- “Inhibition of GSK3B-mediated 53BP1 T334 phosphorylation in T cells Enhances Infiltration and Cytotoxicity Against Head and Neck Squamous Cell Carcinoma”, Jessica Kelliher
- “Comprehensive analysis of proteome turnover dynamics during T cell exhaustion”, Sydnye Shuttleworth
- “Protecting EZH2 activity in T cells to increase melanoma therapy efficacy”, Megan Reed
- “DNA Damage Repair Protein Modulation During T cell Exhaustion”, Kashti Shah
Tackett and Koss Labs Receive R21
Congratulations to Tackett and Koss labs on receiving a $421,000 NCI R21 grant to study cancer-evolved resistance mechanism to enhance adoptive T-cells.